Unigen Pharmaceuticals 29632

Unigen Pharmaceuticals

BROOMFIELD, Colo.Unigen Pharmaceuticals Inc. introduced DiAfin andpolicosanol. DiAfin is a patent-pending compound for weight loss that helpsreduce body fat while maintaining lean muscle mass and positively affectingfructose metabolism. Policosanol is derived from Cera Chinensis and helpsmaintain healthy cholesterol levels and lipoprotein profiles. According toUnigen, policosanol has been found to ameliorate health conditions for which ithas filed patents, including obesity, Syndrome X, diabetes,hypercholesterolemia, atherosclerotic complications, ischema and thrombosis.

For more information, visit www.unigenpharma.comor Booth #1434-1436 at SupplySide East.